The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated ...

The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.

The FDA just approved a new type of pain medication, and it's a non-opioid called suzetrigine that stops body pain at its ...

A new non-opioid pain medication is now on the market, and those who've overcome addiction say this new way to treat pain can save lives. The brand name is Journavx, it is the first new class of pain ...

The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller ...

The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in ...

Will people with acute pain want a new painkiller whose list price is $15.50 a pill when a generic prescription drug is at ...

The U.S. Food and Drug Administration (FDA) approved Thursday a new type of prescription pain medication for moderate to severe acute pain for adults.

The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side ...

The Food and Drug Administration Jan. 30 announced it approved Journavx (suzetrigine) oral tablets, a first-in-class ...

The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...